National Institute of Allergy and Infectious Diseases: Notice of Closed Meetings, 68457 [2014-27058]

Download as PDF Federal Register / Vol. 79, No. 221 / Monday, November 17, 2014 / Notices Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: November 7, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) [FR Doc. 2014–27059 Filed 11–14–14; 8:45 am] Dated: November 7, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P [FR Doc. 2014–27058 Filed 11–14–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY National Institutes of Health National Institute of Allergy and Infectious Diseases: Notice of Closed Meetings asabaliauskas on DSK5VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Modeling Immunity for Biodefense (U19). Date: December 8–10, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton—Silver Spring, Magnolia Ballroom, 8777 Georgia Avenue Silver Spring, MD 20910. Contact Person: Quirijn Vos, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301–451– 2666, qvos@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Beyond HAART: Innovative Approaches to Cure HIV–1 (U19). Date: December 10–12, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, Baccarat Suite, One Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Betty Poon, Ph.D., Scientific Review Officer, Scientific Review Program Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–6891, poonb@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, 17:14 Nov 14, 2014 Jkt 235001 www.regulations.gov. For more information on submitting written comments, see the SUPPLEMENTARY INFORMATION section below. FOR FURTHER INFORMATION CONTACT: Kristin Wyckoff, DHS/S&T/RSD, 445 Murray Lane SW., Mail Stop 0208, Washington, DC 20528–0208. SUPPLEMENTARY INFORMATION: I. Public Participation DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 68457 [Docket No. DHS–2013–0074] Request for Comments and Answers to Specific Questions To Inform Development of the National Critical Infrastructure Security and Resilience (NCISR) Research and Development (R&D) Plan Science and Technology Directorate, DHS. ACTION: Notice and Request for Comments and Answers to Specific Questions. AGENCY: This Notice requests general comments and answers to specific questions to inform development of the National Critical Infrastructure Security and Resilience Research and Development Plan (NCISR R&D Plan) called for in Presidential Policy Directive (PPD) 21, Critical Infrastructure Security and Resilience. As part of a comprehensive national review process, the Department of Homeland Security (DHS) is soliciting public comments to support the DHS Science and Technology Directorate (S&T) in writing the NCISR R&D Plan. Critical infrastructure includes cyber and physical assets, systems, and networks comprising the 16 critical infrastructure sectors identified in PPD– 21. DATES: Written comments are encouraged and will be accepted until December 17, 2014. ADDRESSES: You may submit comments, identified by docket number DHS– 2013–0074, by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. • Email: R&DWG@hq.dhs.gov. Include the docket number DHS–2013– 0074 in the subject line of the message. • Mail: Kristin Wyckoff, DHS/S&T/ RSD, 445 Murray Lane SW., Mail Stop 0208, Washington, DC 20528–0208. Docket: For access to the docket to read background documents or comments received, go to http:// SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 DHS invites interested persons to provide input and answers to specific questions to inform the identification of national R&D priorities for the NCISR R&D Plan. Input is welcome from stakeholder groups, private and public entities, and individuals on content to be included to best fulfill the intended purpose of the plan. Comments that will provide the most assistance to DHS will include a rationale for the stated answer or recommendation, along with supplemental data, information, or authority that supports the response. II. Additional Instructions for Written Submissions All written submissions must include the words ‘‘Department of Homeland Security’’ and the docket number for this action. All comments received (via any of the identified methods) will be posted without change to http:// www.regulations.gov, including any personal information provided. Please submit your comments and material by only one means to avoid the posting of duplicate submissions. If you submit comments by mail, your submission should be an unbound document and no larger than 8.5 by 11 inches to enable copying and electronic document management. Please limit submissions to a maximum of ten pages of text if possible. If you want DHS to acknowledge receipt of comments by mail, include with your comments a self-addressed, stamped postcard that includes the docket number for this action. DHS will date your postcard and return it to you via regular mail. III. Background On February 12, 2013, President Obama signed PPD–21,1 Critical Infrastructure Security and Resilience, which builds on the extensive work done to date to protect and enhance the resilience of the Nation’s critical infrastructure. This directive aims to clarify roles and responsibilities across the Federal Government and establish a more effective partnership with owners 1 PPD–21 can be found at: http:// www.whitehouse.gov/the-press-office/2013/02/12/ presidential-policy-directive-critical-infrastructuresecurity-and-resil. E:\FR\FM\17NON1.SGM 17NON1

Agencies

[Federal Register Volume 79, Number 221 (Monday, November 17, 2014)]
[Notices]
[Page 68457]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27058]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases: Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Modeling Immunity for Biodefense 
(U19).
    Date: December 8-10, 2014.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton--Silver Spring, Magnolia Ballroom, 8777 Georgia 
Avenue Silver Spring, MD 20910.
    Contact Person: Quirijn Vos, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, DHHS/
NIH/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-
451-2666, qvos@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Beyond HAART: Innovative Approaches 
to Cure HIV-1 (U19).
    Date: December 10-12, 2014.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, Baccarat Suite, One Bethesda 
Metro Center, Bethesda, MD 20814.
    Contact Person: Betty Poon, Ph.D., Scientific Review Officer, 
Scientific Review Program Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 
301-402-6891, poonb@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


     Dated: November 7, 2014.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27058 Filed 11-14-14; 8:45 am]
BILLING CODE 4140-01-P